1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with ristocetin in 8 studies
Studies (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Trials (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Studies (ristocetin) | Trials (ristocetin) | Recent Studies (post-2010) (ristocetin) |
---|---|---|---|---|---|
9,156 | 187 | 552 | 1,515 | 23 | 125 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (50.00) | 18.7374 |
1990's | 4 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Takahashi, O | 1 |
Frojmovic, M; Pedvis, L; Wong, T | 1 |
Abbondanza, M; Benedetto, C; Bertini, E; Enrieu, N; Massobrio, M; Tetta, C | 1 |
Asyee, GM; Schaap, MC; Sturk, A; ten Cate, JW; van Maanen, M | 1 |
Du, XP; Gu, JM; Li, PX; Ruan, CG; Wan, HY; Wu, X; Xi, XD | 1 |
Cissik, JH; Dalton, LM; McGlasson, DL; Patterson, WR | 1 |
Cole, AT; Hawkey, CJ; Heptinstall, S; May, JA | 1 |
Kinlough-Rathbone, RL; Packham, MA; Perry, DW; Rand, ML | 1 |
1 trial(s) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and ristocetin
Article | Year |
---|---|
Platelet responses to several agonists and combinations of agonists in whole blood: a placebo controlled comparison of the effects of a once daily dose of plain aspirin 300 mg, plain aspirin 75 mg and enteric coated aspirin 300 mg, in man.
Topics: Adenosine Diphosphate; Adult; Arachidonic Acid; Aspirin; Blood Platelets; Coagulants; Collagen; Dose-Response Relationship, Drug; Epinephrine; Female; Humans; Male; Placebos; Platelet Activating Factor; Platelet Aggregation; Platelet Aggregation Inhibitors; Ristocetin; Streptokinase; Tablets, Enteric-Coated | 1997 |
7 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and ristocetin
Article | Year |
---|---|
Some properties of rat platelet aggregation and effects of butylated hydroxytoluene, warfarin and aspirin.
Topics: Adenosine Diphosphate; Animals; Arachidonic Acid; Arachidonic Acids; Aspirin; Blood Coagulation Factors; Butylated Hydroxytoluene; Collagen; Epinephrine; Male; Platelet Activating Factor; Platelet Aggregation; Rats; Rats, Inbred Strains; Ristocetin; Warfarin | 1991 |
Platelet size affects both micro- and macro-aggregation: contributions of platelet number, volume fraction and cell surface.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adenosine Diphosphate; Adult; Blood Platelets; Cell Membrane; Cell Separation; Humans; Kinetics; Microscopy, Phase-Contrast; Nephelometry and Turbidimetry; Platelet Activating Factor; Platelet Aggregation; Platelet Count; Prostaglandin Endoperoxides, Synthetic; Ristocetin | 1989 |
Reduced serum inhibition of platelet-activating factor activity in preeclampsia.
Topics: Adenosine Diphosphate; Adult; Chromatography, Thin Layer; Collagen; Female; Humans; Platelet Activating Factor; Platelet Aggregation; Pre-Eclampsia; Pregnancy; Ristocetin | 1989 |
Synergistic effects of platelet-activating factor and other platelet agonists in human platelet aggregation and release: the role of ADP and products of the cyclooxygenase pathway.
Topics: Adenosine Diphosphate; Arachidonic Acid; Arachidonic Acids; beta-Thromboglobulin; Blood Platelets; Calcimycin; Collagen; Drug Synergism; Epinephrine; Humans; Kinetics; Platelet Activating Factor; Platelet Aggregation; Ristocetin; Thrombin | 1985 |
Studies on monoclonal antibodies against human platelets--a monoclonal antibody to human platelet glycoprotein I--SZ-2.
Topics: Antibodies, Monoclonal; Collagen; Humans; Platelet Activating Factor; Platelet Aggregation; Platelet Membrane Glycoproteins; Ristocetin | 1987 |
Aggregation of killer whale platelets.
Topics: Adaptation, Physiological; Adenosine Diphosphate; Animals; Arachidonic Acid; Blood Platelets; Calcimycin; Collagen; Dolphins; Epinephrine; Female; Male; Platelet Activating Factor; Platelet Aggregation; Ristocetin; Thromboxane B2; Time Factors | 1993 |
Effects of cathepsin G pretreatment of platelets on their subsequent responses to aggregating agents.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adenosine Diphosphate; Anti-Bacterial Agents; Blood Platelets; Cathepsin G; Cathepsins; Drug Interactions; Hemostatics; Humans; Platelet Activating Factor; Platelet Aggregation; Platelet Glycoprotein GPIb-IX Complex; Ristocetin; Serine Endopeptidases; Serotonin; Thrombin; Vasoconstrictor Agents | 1999 |